1. Human Milk Oligosaccharides Market – Overview
1.1 Definitions and Scope
2. Human Milk Oligosaccharides Market – Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product
2.3 Key trends by Application
2.4 Key trends by Form
2.5 Key trends by Type
2.6 Key trends by Geography
3. Human Milk Oligosaccharides Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split – Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis – Average Selling Price
4. Human Milk Oligosaccharides Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Human Milk Oligosaccharides Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Human Milk Oligosaccharides Market – By Product (Market Size –$Million/$Billion)
6.1 Lacto-N-neotetraose
6.2 Lacto-N-tetraose
6.3 2′-Fucosyllactose
6.4 3′-Fucosyllactose
6.5 3′-Sialyllactose
6.6 6′-Sialyllactose
7. Human Milk Oligosaccharides Market – By Application (Market Size –$Million/$Billion)
7.1 Food Supplements
7.2 Functional food & Beverages
7.3 Infant Formula
7.4 Others
8. Human Milk Oligosaccharides Market – By Type(Market Size –$Million/$Billion)
8.1 Acidic
8.2 Neutral
9. Human Milk Oligosaccharides Market – By Geography(Market Size –$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Mexico
9.1.3 Canada
9.2 Europe
9.2.1 U.K.
9.2.2 France
9.2.3 Germany
9.2.4 Italy
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 India
9.3.3 Japan
9.3.4 South Korea
9.3.5 Australia & New Zealand
9.3.6 Rest of APAC
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Rest of South America
9.5 Rest of the World
9.5.1 Middle East
9.5.2 Africa
10. Human Milk Oligosaccharides Market – Entropy
11. Human Milk Oligosaccharides Market Company Analysis
11.1 Company 1
11.2 Company 2
11.3 Company 3
11.4 Company 4
11.5 Company 5
11.6 Company 6
11.7 Company 7
11.8 Company 8
11.9 Company 9
11.10 Company 10
“*Financials for private companies would be provided on a best efforts basis”.
Report Description
Overview
인간 모유 올리고당(HMOs)은 영유아의 장 건강과 면역 체계를 지원하며, 기능성 식품 및 유아용 조제식품의 중요한 성분으로 사용됩니다.
Segment
이 시장은 제품별로 락토-N-테트라오스(Lacto-N-tetraose), 2'-푸코실락토스(2'-Fucosyllactose) 등으로, 용도별로 유아 조제식, 기능성 식품 및 음료로 구분됩니다. 타입별로는 중성(Neutral), 산성(Acidic)으로 나뉘며, 지역별로는 북미, 유럽, 아시아 태평양(APAC), 남미 및 기타 지역으로 세분화됩니다.
Key Takeaways
HMOs는 영유아 영양 제품뿐만 아니라 성인 기능성 식품에서도 점차 수요가 증가하고 있는 고부가가치 성분입니다.